medical devices and tissue engineering polymers
Viatel™ polymers are used in the fabrication of degradable medical devices and tissue engineering solutions.
In medical device polymer applications, viatel™ polymers provide structural support for a controlled duration of time before they are resorbed by the body. This eliminates the need for surgical removal once the healing process has completed and provides several device specific benefits such as localized drug release opportunities. Their potential doesn’t stop there: everyday new uses for bioresorbable polymers are being explored in regenerative medicine and tissue engineering.
In tissue engineering applications, viatel™ polymers are used to create temporary scaffolds which can help repair, replace, or regenerate tissue in the human body and thereby assist organs to repair themselves following disease, injury, or incapacity.
Typically, therefore, Viatel™ polymers are intended to be used as components to create:
- bioresorbable implants, plates and screws for trauma and orthopedics
- bioresorbable stents and device coatings for cardiovascular treatments
- wider medical devices such as neural conduits, hernia meshes, dental and ophthalmic treatments
- injectable hydrogels
- hard (e.g., bone) and soft (e.g., skin) tissue regeneration scaffolds
- wound closure devices such as staples and sutures
These polymers have a proven safety track record, are completely metabolized and are easily processed by way of 3D printing, injection molding, hot melt extrusion, and other techniques.
Ashland offers:
Viatel™ bioresorbable polymers in custom formulations
Our team of experts can assist with :
- polymer selection
- customized polymer solutions
- processing technologies
- characterization of materials and behaviors to assist in development process
read more >
viatel™ bioresorbable polymers
Viatel bioresorbable polymers are a platform of lactide/glycolide/caprolactone-based polyester chemistries.
natrosol™ hydroxyethylcellulose
Natrosol™ pharm HEC grades are non-ionic, water-soluble polymer widely used in pharmaceutical formulations. This product is easily dispersed in cold or hot water to give solutions of varying viscosities and desired properties, though it is insoluble in organic solvents. It is used in solutions and gels to control rheology, in emulsions for high-salt tolerance and surfactant compatibility, and in modified-release matrix tablets where high-vi...
natrosol™ 250 l pharm hydroxyethylcellulose
Hydroxyethylcellulose (HEC) is a non-ionic, water-soluble polymer widely used in pharmaceutical formulations.
viatel™ bioresorbable polymer
Ashland’s bioresorbable polymers technology platform is scalable and includes multiple market segments and potential applications including long acting injectables for chronic disease, and animal health; advanced drug delivery for improved mRNA delivery; and medical devices and regenerative medicine for dermal fillers, sutures, screws and more. Designed for use in the pharmaceutical and medical industries, Viatel™ bioresorbable poly...
plasdone™ povidone
Ashland offers a comprehensive range of Plasdone™ povidones (PVP). Plasdone™ povidones are a family of water-soluble polymers based on N-vinylpyrrolidone that combine a unique set of properties for application in a wide variety of dosage forms. Plasdone™ povidones are commonly used as binders for the development of tablet formulations, whether manufactured by wet granulation, dry granulation or direct compression. Plasdone&trade...
pvp k-81|86 mb
Polyvinylpyrrolidone is a hygroscopic, amorphous polymer supplied as a white, free-flowing powder or a clear aqueous solution. Available in several molecular weight grades, they are characterized by K-value, and used in a great variety of applications. Polyvinylpyrrolidone can be plasticized with water and most common organic plasticizers. It is considered to be physiologically inert
viatel™ ultrapure bioresorbable polymers
Viatel™ Ultrapure high-purity bioresorbable polymers for long-acting injectables and implants offer improved stability and achieve longer, more consistent drug release profiles; they are better suited for sensitive drug compounds in long-acting injectables and implants (LAII). Removing residual monomer reduces acidic equivalents and results in a more consistent rate of water uptake and degradation kinetics. This means more reproducible performanc...